Literature DB >> 28898216

CRISPR patent estate splinters.

Cormac Sheridan.   

Abstract

Mesh：

Year:  2017        PMID： 28898216     DOI： 10.1038/nbt0917-808b

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection.

Authors:  Justin Eyquem; Jorge Mansilla-Soto; Theodoros Giavridis; Sjoukje J C van der Stegen; Mohamad Hamieh; Kristen M Cunanan; Ashlesha Odak; Mithat Gönen; Michel Sadelain
Journal:  Nature       Date:  2017-02-22       Impact factor: 49.962
  1 in total
  2 in total

1.  Gut bacteria link to immunotherapy sparks interest.

Authors:  Brian Owens
Journal:  Nat Biotechnol       Date:  2018-02-06       Impact factor: 54.908

Review 2.  Advancing biotechnology with CRISPR/Cas9: recent applications and patent landscape.

Authors:  Raphael Ferreira; Florian David; Jens Nielsen
Journal:  J Ind Microbiol Biotechnol       Date:  2018-01-24       Impact factor: 3.346
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.